摘要
目的对厄贝沙坦胃滞留夹芯渗透泵片(SOPT)的制备方法进行研究,并考察其体外释放度。方法分别以膨胀速度、水渗透速率、低剪切黏度、屈服应力及释放度为评价指标,确定处方中膨胀剂材料、致孔剂、助悬剂、促渗剂的用量。结果最佳处方:膨胀剂为PEO(Mw 5 000 000)与HPMC混合物(4∶1),用量70 mg;促渗剂氯化钠用量为25 mg;包衣液致孔剂PEG400用量8%;助悬剂PEO(Mw 200 000),用量为厄贝沙坦的1/4。释药行为符合零级方程,具有明显的控释特征。结论 SOPT具有良好的体外控释效果,可进一步进行体内释药行为考察。
OBJECTIVE To study prescription and technique of intragastric floating sandwiched osmotic pump tablets (SOPT) of irbesartan and inspect release property in vitro. METHODS The swelling rate, permeation rate of water, shear viscosity of slow-speed revolution, yield stress and release property was inspected to determine the dosage of the swelling agent, porous agent, suspending agent and osmotic agent. RESULTS The optimization of prescription and technique were definited: swelling agent was a mixture of PEO(Mw 5 000 000) and HPMC as a ratio of 4 : 1 (the dosage was 70 mg); osmotic agent sodium chloride was 25 mg; porous agent PEG 400 was 8%; the ratio of suspending agent PEO(Mw 200 000) to irbesartan was 1 : 4. The release behavior of SOPT coincidented with zero-level equation well and the character of controlled-release was transparent. CONCLUSION SOPT has good controlled-release in vitro and the release behavior in vivo need to be investigated.
出处
《中国现代应用药学》
CAS
CSCD
2013年第2期154-157,共4页
Chinese Journal of Modern Applied Pharmacy
关键词
厄贝沙坦
夹芯渗透泵片
胃滞留
体外释放
irbesartan
sandwiched osmotic pump tablets
intragastric floating
release in vitro